Evidence map›Paper›PMID 26905391›Full record

ArticleNature communications2016

Structural hot spots for the solubility of globular proteins.

Ashok Ganesan, Aleksandra Siekierska, Jacinte Beerten, Marijke Brams, Joost Van Durme, Greet De Baets, Rob Van der Kant, Rodrigo Gallardo, Meine Ramakers, Tobias Langenberg and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. CsgA gatekeeper residues control nucleation but not stability of functional amyloid.Protein science : a publication of the Protein Society · 2024
    Article
  9. Mechanisms and pathology of protein misfolding and aggregation.Nature reviews. Molecular cell biology · 2023
    Review
  10. Article
  11. Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Learning the relationship between nanoscale chemical patterning and hydrophobicity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. A3D 2.0 Update for the Prediction and Optimization of Protein Solubility.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Ashok GanesanVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Aleksandra SiekierskaVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Jacinte BeertenVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Marijke BramsKU Leuven, Laboratory for Structural Neurobiology, Department of Cellular and Molecular Medicine, Herestraat 49, PB 601, B-3000 Leuven, Belgium.
Joost Van DurmeVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Greet De BaetsVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Rob Van der KantVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Rodrigo GallardoVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Meine RamakersVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Tobias LangenbergVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Hannah WilkinsonVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Frederik De SmetVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Chris UlensKU Leuven, Laboratory for Structural Neurobiology, Department of Cellular and Molecular Medicine, Herestraat 49, PB 601, B-3000 Leuven, Belgium.
Frederic RousseauVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Joost SchymkowitzVIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), 3000 Leuven, Belgium.
Vlaams Instituut voor Biotechnologie · BEKU Leuven · BEVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural selection shapes protein solubility to physiological requirements and recombinant applications that require higher protein concentrations are often problematic. This raises the question whether the solubility of natural protein sequences can be improved. We here show an anti-correlation between the number of aggregation prone regions (APRs) in a protein sequence and its solubility, suggesting that mutational suppression of APRs provides a simple strategy to increase protein solubility. We show that mutations at specific positions within a protein structure can act as APR suppressors without affecting protein stability. These hot spots for protein solubility are both structure and sequence dependent but can be computationally predicted. We demonstrate this by reducing the aggregation of human α-galactosidase and protective antigen of Bacillus anthracis through mutation. Our results indicate that many proteins possess hot spots allowing to adapt protein solubility independently of structure and function.

Indexed as

alpha-GalactosidaseAmino Acid SequenceAntigens, BacterialBacterial ToxinsBlotting, WesternCell Line, TumorChromatography, GelCrystallography, X-RayElectrophoresis, Polyacrylamide GelHeLa CellsHumansMutationProtein StabilitySolubilityalpha-Galactosidaseanthrax toxinAntigens, BacterialBacterial Toxins

Identifiers

PMID26905391
PMCPMC4770091
OpenAlexW2289037553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.